Treating multidrug-resistant tuberculosis in Tomsk, Russia: Developing programs that address the linkage between poverty and disease

Annals of the New York Academy of Sciences

Volumn 1136, Issue , 2008, Pages 1-11

  Keshavjee, S ^a,b,c   Gelmanova, I Y ^c   Pasechnikov, A D ^c   Mishustin, S P ^d   Andreev, Y G ^e   Yedilbayev, A ^c   Furin, J J ^a,c   Mukherjee, J S ^a,b,c   Rich, M L ^a,c   Nardell, E A ^a,b,c,f   Farmer, P E ^a,b,c   Kim, J Y ^a,b,c,f   Shin, S S ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PARTNERS IN HEALTH   (United States)

^d Tomsk Oblast Tuberculosis Services   (Russian Federation)

^e Ministry of Justice   (Russian Federation)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

DOTS; DOTS Plus; Drug resistant tuberculosis; Inequality; MDR TB; Partners In Health; Poverty; Russia; Scaleup of MDR TB treatment; Tomsk

Indexed keywords

AMBULATORY CARE; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG MANUFACTURE; DRUG QUALITY; DRUG SENSITIVITY; EPIDEMIC; HEALTH CARE AVAILABILITY; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOME CARE; INCIDENCE; INFECTION CONTROL; MORTALITY; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; PATIENT MONITORING; POLITICS; POVERTY; PREVALENCE; PRISON; PROGRAM DEVELOPMENT; REVIEW; RUSSIAN FEDERATION; SOCIOECONOMICS; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 45549107876     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1425.009     Document Type: Review

References (117)

1. World Health Organization. 2002. STOP TB Annual Report 2001. World Health Organization. Geneva.
2. World Health Organization. 1997. WHO Report on the Tuberculosis Epidemic. World Health Organization. Geneva.
3. World Health Organization. 1999. Global Tuberculosis Control, WHO Report 1999. World Health Organization. Geneva.
4. Nardell, E. 1989. Tuberculosis in homeless, residential care facilities, prisons, nursing homes, and other close communities. Semin. Respir. Infect. 4:206 215.
5. Centers for Disease Control and Prevention. 1998. Recommendations for prevention and control of tuberculosis among foreign-born persons: report of the working group on tuberculosis among foreign-born persons. MMWR Recomm. Rep. 47 (No. RR-16 1 29.
6. Moore, M., E. McCray & I. Onorato. 1999. Cross matching TB and AIDS registries: TB patients with HIV coinfection, United States, 1993-1994. Public Health Rep. 114:269 277.
7. Murray, J. 1991. Tuberculosis and human immunodeficiency virus infections during the 1990s. Bull. Int. Union Tuberc. Lung Dis. 66:21 25.
8. Mitchison, D.A. & A.J. Nunn. 1986. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am. Rev. Respir. Dis. 122:423 430.
9. Pablos-Mendez, A. et al. 2001. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization - International Union against Tuberculosis and Lung Disease Working Group on anti-tuberculosis drug resistance surveillance. N. Engl. J. Med. 344:1294 1303.
10. Neville, K. et al. 1994. The third epidemic - multi-drug resistant tuberculosis. Chest 105:45 48.
11. Blower, S., P. Small & P. Hopewell. 1996. Control strategies for tuberculosis epidemics: new models for old problems. Science 273:497 500.
12. Iseman, M.D. & M. Goble. 1996. Multidrug-resistant tuberculosis. N. Engl. J. Med. 334:267.
13. Espinal, M.A. et al. 2000. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 283:2537 2545.
14. Cohen, T. & M. Murray. 2004. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat. Med. 10:1117 1121.
15. Blower, S.M. & T. Chou. 2004. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat. Med. 10:1111 1116.
16. Migliori, G.B. et al. 2000. Frequency of recurrence among MDR-TB cases 'successfully' treated with standardised short-course chemotherapy. Int. J. Tuberc. Lung Dis. 6:858 864.
17. Frieden, T.R. et al. 1995. Tuberculosis in New York City - turning the tide. N. Engl. J. Med. 333:229 233.
18. Frieden, T.R. et al. 1996. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276:1229 1235.
19. Vailway, S. et al. 1994. Multidrug-resistant tuberculosis in the New York state prison system, 1990-1991. J. Infect. Dis. 170:151 156.
20. Nardell, E. et al. 1986. Exogenous reinfection with tuberculosis in a shelter for the homeless. N. Engl. J. Med. 315:1570 1573.
21. Beck-Sague, C. et al. 1992. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 268:1280 1286.
22. Barnes, P. et al. 1996. Transmission of tuberculosis among the urban homeless. JAMA 275:305 307.
23. Pablos-Mendez, A. et al. 1990. Drug resistant tuberculosis among the homeless in New York City. N. Y. State J. Med. 90:351 355.
24. Kritski, A. et al. 1996. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 153:331 335.
25. Rullán, J. et al. 1996. Nosocomial transmission of multidrug-resistant tuberculosis in Spain. Emerg. Infect. Dis. 2:125 129.
26. Gandhi, N.R. et al. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575 1580.
27. WHO. 2006. Case definition for extensively drug-resistant tuberculosis. Wkly. Epidemiol. Rec. 81:408.
28. World Health Organization. 2000. Anti-tuberculosis drug resistance in the world, report no. 2: The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 2000. World Health Organization. Geneva.
29. Li, X. et al. 2007. Transmission of drug-resistant tuberculosis among treated patients in Shanghai, China. J. Infect. Dis. 195:864 869.
30. Zignol, M. et al. 2006. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 194:479 485.
31. Farmer, P.E. et al. 1997. Poverty, inequality, and drug resistance: meeting community needs. Proceedings of the Int. Union Tuberc. Lung Dis. North Am. Regional Conference 88 102.
32. Farmer, P.E. et al. 1999. Recrudescent tuberculosis in the Russian Federation. In The Global Impact of Drug-Resistant Tuberculosis. 39 84. Harvard Medical School and Open Society Institute. Boston, MA.
33. Centers for Disease Control and Prevention. 1999. Primary multidrug-resistant tuberculosis - Ivanovo Oblast, Russia, 1999. MMWR Morb. Mortal. Wkly. Rep. 48:661 663.
34. Coninx, R. et al. 1998. Drug resistant tuberculosis in prisons in Azerbaijan: case study. BMJ 316:1423 1425.
35. Kimerling, M. et al. 1999. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int. J. Tuberc. Lung Dis. 3:451 453.
36. Seung, K.J. et al. 2004. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clin. Infect. Dis. 39:1321 1328.
37. Kim, J.Y. et al. 2003. From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift. Tuberculosis 83:59 65.
38. Iseman, M.D. 1998. MDR-TB and the developing world - a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy. Int. J. Tuberc. Lung Dis. 2:867.
39. World Health Organization. 2000. Guidelines for establishing DOTS-Plus pilot projects for the management of MDR-TB. R. Gupta & T. Arnadottir, Eds. 279. WHO. Publication WHO/CDS/TB/2000. Geneva, Switzerland.
40. Kochi, A. 1997. Tuberculosis control - is DOTS the health breakthrough of the 1990s? World Health Forum 18:225 232.
41. Farmer, P.E. & J.Y. Kim. 1998. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus". BMJ 317:671 674.
42. Coordination of DOTS-Plus pilot projects for the management of MDR-TB. 1999. WHO/CDS/CPC/TB/99.262. Geneva, Switzerland.
43. WHO. 2002. DOTS-Plus: Preliminary results and emerging issues. Proceedings of the Meeting of the Stop TB Working Group on DOTS-Plus for MDR-TB, Tallinn, Estonia, 10-12 April 2002. Geneva, Switzerland, 2002. WHO/CDS/TB/2002.307.
44. Gupta, R. et al. 2002. Increasing transparency in partnerships for health - introducing the Green Light Committee. Trop. Med. Int. Health 7:970 976.
45. Shin, S. et al. 2004. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc. Sci. Med. 59:1529 1539.
46. Mitnick C.D. et al. 2003. Community-based therapy for multi-drug resistant tuberculosis in Lima, Peru. N. Engl. J. Med. 348:1219 1228.
47. Centers for Disease Control and Prevention. 1990. Outbreak of multidrug-resistant tuberculosis - Texas, California, and Pennsylvania. MMWR Morb. Mortal. Wkly. Rep. 39:369 373.
48. Iseman, M.D. et al. 1990. Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 141:623 625.
49. Suarez, P.G. et al. Feasibility and cost-effectiveness of standardized second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet 359:1980 1989.
50. Farmer, P.E., J.J. Furin & S.S. Shin. 2000. Managing multidrug-resistant tuberculosis. J. Respir. Dis. 21:53 56.
51. Park, S.K., C.T. Kim & S.D. Song. 1998. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. Int. J. Tuberc. Lung Dis. 2:877 884.
52. Telzak, E.E. et al. 1995. Multidrug-resistant tuberculosis in patients in patients without HIV infection. N. Engl. J. Med. 333:907 903.
53. Farmer, P.E. et al. 2000. Responding to outbreaks of multidrug-resistant tuberculosis: introducing DOTS-Plus. In Tuberculosis: a comprehensive International Approach, 2nd edition. L. Reichman & E.S. Hershfield, Eds 447 469. Marcel Dekker, Inc. New York, NY.
54. Leimane, V. et al. 2005. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 365:318 326.
55. World Health Organization. 2007. The Global MDR-TB & XDR-TB Response Plan 2006-2007. WHO. Geneva. Publication: WHO/HTM/TB/2007.387.
56. Vermiere, E. et al. 2001. Patient adherence to treatment: three decades of research. A comprehensive review. J. Clin. Pharm. Ther. 26:331 342.
57. Addington, W. 1997. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest 76:741 743.
58. Sumartojo, E. 1993. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am. Rev. Respir. Dis. 147:1311 1320.
59. Centers for Disease Control and Prevention. 1999. Primary multidrug-resistant tuberculosis - Ivanovo Oblast, Russia, 1999. MMWR Morb. Mortal. Wkly. Rep. 48:661 663.
60. Raviglione, M.C. et al. 1994. Tuberculosis trends in eastern Europe and the former USSR. Tuber. Lung Dis. 75:400 416.
61. Kimerling, M.E. 2000. The Russian equation: an evolving paradigm in tuberculosis control. Int. J. Tuberc. Lung Dis. 4 (Suppl 2 S160 S167.
62. Cockerham, W.C. 2007. Health lifestyles and the absence of the Russian middle class. Sociol. Health Illn. 29:457 473.
63. Notzon, F.C. et al. 1998. Causes of declining life expectancy in Russia. JAMA 279:793 800.
64. Liu, Y., K. Rao & J. Fei. 1998. Economic transition and health transition: comparing China and Russia. Health Policy 44:103 122.
65. Carlson, P. 2005. Relatively poor, absolutely ill? A study of regional income inequality in Russia and its possible health consequences. J. Epidemiol. Community Health 59:389 394.
66. Shkolnikov, V.M. et al. 1998. Educational level and adult mortality in Russia: an analysis of routine data 1979 to 1994. Soc. Sci. Med. 47:357 369.
67. Chenet, L. et al. 1998. Deaths from alcohol and violence in Moscow: socio-economic determinants. Eur. J. Popul. 14:19 37.
68. Plavinski, S.L., S.I. Plavinskaya & A.N. Klimov. 2003. Social factors and increase in mortality in Russia in the 1990s: prospective cohort study. BMJ 326:1240 1242.
69. Murphy, M. et al. 2006. The widening gap in mortality by educational level in the Russian Federation, 1980-2001. Am. J. Public Health 96:1293 1299.
70. Shkolnikov, V.M. et al. 2006. The changing relation between education and life expectancy in central and eastern Europe in the 1990s. J. Epidemiol. Community Health 60:875 881.
71. Bobak, M. et al. 1998. Socioeconomic factors, perceived control and self-reported health in Russia. A cross-sectional survey. Soc. Sci. Med. 47:269 279.
72. Rose, R. 2000. How much does social capital add to individual health? A survey study of Russians. Soc. Sci. Med. 51:1421 1435.
73. McKeehan IV. 2000. A multilevel city health profile of Moscow. Soc. Sci. Med. 51:1295 1312.
74. Bobak, M. et al. 2000 Socioeconomic factors, material inequalities, and perceived control in self-rated health: cross-sectional data from seven post-communist countries. Soc. Sci. Med. 51:1343 1350.
75. Ciment, J. 1999. Health situation in former communist bloc is dire, says Unicef. BMJ 319:1324.
76. Walberg, P. et al. 1998. Economic change, crime, and mortality crisis in Russia: regional analysis. BMJ 317:312 318.
77. Field, M.G., D.M. Kotz & G. Bukhman. 2000. Neoliberal economic policy, "state desertion", and the Russian health crisis. In Dying for Growth: Global Inequality and the Health of the Poor. J.Y. Kim, J.V. Millen, J. Gershman & A. Irwin, Eds 155 173 Common Courage Press. Monroe, ME.
78. Shilova, M.V. 2002. Tuberculosis in Russia in 2001 In Russian Institute of Pthisio-pulmonology of the Sechenov Moscow Medical Academy. Moscow, Russia.
79. Perelman, M. 2000. Tuberculosis in Russia. Int. J. Tuberc. Lung Dis. 4:1097 1103.
80. The number of oblasts included in the Siberian region changed in 1999, making it difficult to compare the values in 2000 to those previously.
81. Dewan, P.K. et al. 2004. Risk factors for death during tuberculosis treatment in Orel, Russia. Int. J. Tuberc. Lung Dis. 8:598 602.
82. McKee, M. & B. Jacobson. 2000. Public health in Europe. Lancet 356:665 670.
83. Drobniewski, F. 1995. Tuberculosis in prisons - forgotten plague. Lancet 346:948 949.
84. Portaels, F., L. Rigouts, & I. Bastian. 1999. Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union. Int. J. Tuberc. Lung Dis. 3:582 588.
85. Public Health Research Institute Center. Key features of Russian TB epidemic. PHRI. http://www.russia.phri.org/tbinrussia.htm, Feb. 25, 2001.
86. Kimerling, M. 2000. The Russian equation: an evolving paradigm in tuberculosis control. Int. J. Tuberc. Lung Dis. 4:5160 5167.
87. Tanne, J.H. 1999. Drug resistant TB is spreading worldwide. BMJ 319:1220.
88. Kimerling, M.E. et al. 2003. The risk of MDR-TB and polyresistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999. Int. J. Tuberc. Lung Dis. 7:866 872.
89. Slavuckij, A. et al. 2002. Decentralization of the DOTS program within a Russian penitentiary system: how to ensure the continuity of tuberculosis treatment in pre-trial detention centers. Eur. J. Public Health 12:94 98.
90. Coker, R.J., R.A. Atun & M. McKee. 2004. Health-care system frailties and public health control of communicable disease on the European Union's new eastern border. Lancet 363:1389 1392.
91. Coker, R.J. et al. 2005. Health system frailties in tuberculosis service provision in Russia: an analysis through the lens of formal nutritional support. Public Health 119:837 843.
92. Atun, R.A. et al. 2005. Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data. Int. J. Tuberc. Lung Dis. 9:1140 1146.
93. Gelmanova, I.Y. et al. 2007. Barriers to successful tuberculosis treatment in Tomsk, Russia; non-adherence, default, and the acquisition of multi-drug resistance. Bull. WHO 85 (9 703 711.
94. Centers for Disease Control and Prevention. Major TB guidelines. http://www.cdc.gov/tb/pubs/mmwr/Maj_guide/cdc_ats_guidelines.htm.
95. Drobniewski, F. et al. 1996. Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment. Tuber. Lung Dis. 77:297 301.
96. Drobniewski, F. et al. 1996. Tuberculosis in Siberia: 1. An epidemiological and microbiological assessment. Tuber. Lung Dis. 77:199 206.
97. Bonnet, M. et al. 2005. Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries. Int. J. Tuberc. Lung Dis. 9:1147 1154.
98. Ruohonen, R.P. et al. 2002. Implementation of the DOTS strategy for tuberculosis in the Leningrad Region, Russian Federation (1998-1999). Int. J. Tuberc. Lung Dis. 6:192 197.
99. Tomskoblkomstat. Yearly Statistical Brochure [In Russian], 2003.
100. Clowes, C.I. 1997. Tomsk Region Tuberculosis services; a review of services and management structures for treatment of tuberculosis in the Tomsk Region of Siberia. MERLIN. London. Cited in: Mawer C, Ignatenko NV, Wares DF, Strelis AK, Golubchikova VT, Yanova GV, Lyagoshina TV, Sharaburova OE, Banatvala N. Comparison of the effictiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia. The Lancet, August 11, 2001; Vol 358, 445-449.
101. Tomsk Oblast Tuberculosis Services, Tomsk, Russian Federation, July 2005.
102. Tomsk Oblast Penitentiary Tuberculosis Services, Tomsk, Russian Federation, July 2005.
103. Ministry of Health, Russian Federation. 2003. Prikaz of 21 March, 2003, No. 109: On improving anti-tuberculosis activities in the Russian Federation [In Russian]. Moscow, March 21.
104. Tomsk TB Registry. 2007. Referred to in: Tomsk Oblast Tuberculosis Services. Round 7 application to the Global Fund to fight AIDS, TB and Malaria, June.
105. Shin, S.S. et al. 2006. Treatment outcomes in an Integrated Civilian and Prison Multidrug-resistant Tuberculosis Treatment Program in Russia. Int. J. Tuberc. Lung Dis. 10:402 408.
106. Tahaoǧlu, K. et al. 2001. The treatment of multidrug-resistant tuberculosis in Turkey. N. Engl. J. Med. 345:170 174.
107. Chan, E. et al. 2004. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am. J. Respir. Crit. Care Med. 169:1103 1109.
108. Leimane, V. et al. 2005. Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 365:318 326.
109. Neville, K. et al. 1994. The third epidemic - multidrug-resistant tuberculosis. Chest 105:45 48.
110. Shin, S. 2007. Extensively Resistant Tuberculosis (XDR-TB): Management and outcomes: Peru and Tomsk. Presented at the American Society for Microbiology 107th General Meeting. Toronto: May 2007.
111. Behforouz, H.L., P.E. Farmer & J.S. Mukherjee. 2004. From directly observed therapy to accompagnateurs: Enhancing AIDS treatment outcomes in Haiti and in Boston. Clin. Infect. Dis. 38:S429 S436.
112. Farmer, P.E., B. Nizeye, S. Stulac, et al. 2006. Structural Violence and Clinical Medicine. PLoS Med. 3:1686 1691.
113. Partners In Health, Russia. June 2007.
114. Sterling, T.R., H.P. Lehmann & T.R. Frieden. 2003. Impact of DOTS compared with DOTS-Plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis. BMJ 326:574.
115. Coker, R. 2002. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? Int. J. Tuberc. Lung Dis. 6:649 650.
116. Pilote, L. et al. 1996. Tuberculosis prophylaxis in the homeless: a trial to improve adherence to referral. Arch. Intern. Med. 156:161 165.
117. Malotte, C.K., F. Rhodes & K.E. Mais. 1998. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am. J. Public Health 88:792 796.